CN Patent
CN103948545B — 用于药物输送的脂质体
Assigned to Ipsen Biopharm Ltd · Expires 2017-10-03 · 9y expired
What this patent protects
本发明提供了含有取代的铵和/或聚阴离子、和任选地带有期望的治疗实体或成像实体的脂质体组合物。本发明也提供了制备本发明提供的脂质体组合物的方法。
USPTO Abstract
本发明提供了含有取代的铵和/或聚阴离子、和任选地带有期望的治疗实体或成像实体的脂质体组合物。本发明也提供了制备本发明提供的脂质体组合物的方法。
Drugs covered by this patent
- Camptosar (Irinotecan Hydrochloride) · Pfizer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.